Skip to main content
Top

Clinical and Translational Oncology

Issue 6/2011

Content (12 Articles)

Editorial

The importance of the White Book of Radiation Oncology

Ferran Guedea, Alfredo Ramos

Educational Series

microRNAs as novel epigenetic biomarkers for human cancer

María Cortés-Sempere, Inmaculada Ibáñez de Cáceres

Educational Series

Metformin: a new option in cancer treatment

Cristóbal Belda-Iniesta, Olga Pernía, Rafael Simó

Educational Series

PET-CT in the staging and treatment of non-small-cell lung cancer

Patricia Ibeas, Blanca Cantos, José Manuel Gasent, Begoña Rodríguez, Mariano Provencio

Educational Series

Current opinion in cervix carcinoma

Silvia Rodríguez Villalba, Carmen Díaz-Caneja Planell, José Manuel Cervera Grau

Special Article

The White Book of Radiation Oncology in Spain

Ismael Herruzo, Jesús Romero, Amalia Palacios, Ana Mañas, Pilar Samper, Eloísa Bayo, Ferran Guedea

Research Articles

The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression

María José Safont, Mireia Gil, Rafael Sirera, Eloísa Jantus-Lewintre, Elena Sanmartín, Sandra Gallach, Cristina Caballero, Nieves del Pozo, Eugenio Palomares, Carlos Camps

Research Articles

The EORTC information questionnaire, EORTC QLQ-INFO25. Validation study for Spanish patients

Juan Ignacio Arraras, Ana Manterola, Berta Hernández, Fernando Arias de la Vega, Maite Martínez, Meritxell Vila, Clara Eito, Ruth Vera, Miguel Ángel Domínguez

Research Articles

Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

Vega Iranzo, Rafael Sirera, Alfredo Carrato, Andrea Cabrera, Eloísa Jantus, Ricardo Guijarro, Elena Sanmartín, Ana Blasco, Mireia Gil, Lorenzo Gómez-Aldaraví, José Luis González-Larriba, Bertomeu Massuti, Amalia Velasco, Mariano Provencio, Rafael Rosell, Carlos Camps

Research Articles

Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients

Toshiaki Watanabe, Takashi Kobunai, Yoko Yamamoto, Keiji Matsuda, Soichiro Ishihara, Keijiro Nozawa, Hisae Iinuma, Tsuyoshi Konishi, Hisanaga Horie, Hiroki Ikeuchi, Kiyoshi Eshima, Tetsuichiro Muto

Research Articles

Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status

Alfonso Sánchez-Muñoz, Elisabeth Pérez-Ruiz, María Isabel Sáez, José Manuel Trigo, M. Mar Galindo, Lourdes Manzaneque, Begoña Jiménez, Begoña Muros, Emilio Alba

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine